United States · FDA National Drug Code directory
CINVANTI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47426-201_94c147fd-c8bd-428c-911b-f1aba4ab8729
- Product NDC
- 47426-201
- Form
- INJECTION, EMULSION
- Composition / generic term
- aprepitant
- Labeler
- Heron Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180103
- Source listing expiry
- 20271231
Source-listed ingredients
- APREPITANT — 130 mg/18mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS · 47426-201-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →